Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › ID › Nampa › NPI 1659371870
Clinic

Saint Alphonsus Medical Center Nampa, INC.

Saint Alphonsus Medical Center Nampa, INC. was paid $3.70M by Medicaid between Jan 2018 and Dec 2024, across 194 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 31% of everything it billed.

33Billing provider infoSAINT ALPHONSUS MEDICAL CENTER NAMPA, INC.
NAMPA, ID 83687
33aNPI1659371870assigned 07/29/2005
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$3.70M
24GClaims228,751
24DCodes billed194
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Multi-Specialty Clinic/Center providers in Idaho

Rank by total paid#5 of 21
Median peer was paid$151K
This provider vs. median25×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201861,211$1.10M
201978,112$1.48M
202049,420$852K
20219,141$90K
202210,380$73K
202310,849$65K
2024incomplete9,638$40K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
41899 Unlisted procedure, dentoalveolar structures 31% 619 582 $1.14M
74177 Computed tomography, abdomen and pelvis; with contrast material 9.2% 2,669 2,514 $340K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 6.2% 2,753 2,691 $231K
80053 Comprehensive metabolic panel 3.6% 21,026 16,240 $132K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2.8% 1,399 1,264 $103K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.7% 22,108 16,848 $101K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 2.6% 2,705 2,275 $95K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.6% 2,202 1,892 $95K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.5% 2,213 1,795 $91K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.8% 1,357 1,264 $65K
70450 Computed tomography, head or brain; without contrast material 1.6% 1,424 1,334 $58K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.5% 9,825 6,756 $55K
182 more codes
71275 Computed tomographic angiography, chest, with contrast material 1.3% 438 $48K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.3% 120 $47K
76705 Ultrasound, abdominal, real time with image documentation; limited 1.0% 908 $38K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.0% 539 $37K
36415 Collection of venous blood by venipuncture <1% 22,407 $36K
71046 Radiologic examination, chest; 2 views <1% 2,615 $32K
87634 <1% 420 $32K
72125 Computed tomography, cervical spine; without contrast material <1% 471 $29K
84484 <1% 5,559 $28K
77067 Screening mammography, bilateral, including computer-aided detection <1% 662 $27K
84443 Thyroid stimulating hormone (TSH) <1% 2,223 $26K
83690 <1% 5,145 $25K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 302 $25K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 431 $23K
76830 Ultrasound, transvaginal <1% 361 $22K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 603 $22K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 139 $21K
71045 Radiologic examination, chest; single view <1% 4,481 $21K
J2469 Injection, palonosetron hcl, 25 mcg <1% 173 $21K
96361 Intravenous infusion, hydration; each additional hour <1% 1,423 $20K
76801 <1% 338 $19K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 495 $18K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 495 $18K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 566 $17K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 275 $17K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,425 $16K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,555 $16K
81025 <1% 2,224 $15K
83880 <1% 943 $15K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 311 $14K
81001 <1% 5,596 $13K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 262 $13K
84703 <1% 1,726 $13K
84702 <1% 756 $11K
J2785 Injection, regadenoson, 0.1 mg <1% 138 $11K
83605 <1% 1,526 $11K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 796 $10K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,243 $10K
96375 Therapeutic injection; each additional sequential IV push <1% 1,989 $10K
81003 <1% 5,123 $9K
84439 <1% 1,168 $8K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 390 $8K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,566 $8K
87040 <1% 1,057 $8K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 850 $8K
J2704 Injection, propofol, 10 mg <1% 2,132 $8K
87077 <1% 1,071 $8K
80061 Lipid panel <1% 752 $7K
82248 <1% 1,567 $7K
70551 Magnetic resonance imaging, brain; without contrast material <1% 78 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,329 $6K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 191 $6K
83735 <1% 1,792 $6K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 142 $6K
87186 <1% 848 $6K
87400 <1% 251 $6K
80048 Basic metabolic panel (calcium, ionized) <1% 1,063 $6K
76642 <1% 186 $6K
85379 <1% 707 $5K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,506 $5K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 1,125 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,233 $5K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,195 $5K
82550 <1% 1,211 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,424 $5K
85610 <1% 2,141 $5K
85027 <1% 929 $5K
73610 <1% 304 $5K
83036 Hemoglobin; glycosylated (A1C) <1% 760 $5K
87081 <1% 740 $5K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 161 $5K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,264 $5K
73630 <1% 349 $5K
82728 <1% 527 $5K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,367 $4K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) <1% 20 $4K
73130 <1% 261 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 974 $4K
87486 <1% 120 $4K
87581 <1% 120 $4K
86140 <1% 982 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,843 $4K
87280 <1% 272 $4K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 830 $4K
85730 <1% 853 $4K
87210 <1% 695 $3K
84466 <1% 426 $3K
74018 <1% 251 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,246 $3K
86003 <1% 29 $3K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 72 $3K
82553 <1% 452 $3K
J0780 Injection, prochlorperazine, up to 10 mg <1% 380 $3K
73110 <1% 152 $3K
80306 <1% 198 $3K
90715 <1% 108 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 489 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 40 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,108 $2K
82803 <1% 152 $2K
73562 <1% 143 $2K
97162 <1% 56 $2K
87070 <1% 265 $2K
86901 <1% 689 $2K
73030 <1% 163 $2K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 16 $2K
86900 <1% 670 $2K
83540 <1% 436 $2K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 39 $2K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 72 $2K
85652 <1% 873 $2K
72100 <1% 98 $1K
82607 <1% 126 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 652 $1K
74220 <1% 27 $1K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 91 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,437 $1K
86850 <1% 185 $1K
83615 <1% 223 $972.38
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 13 $964.81
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 15 $955.64
J7050 Infusion, normal saline solution, 250 cc <1% 949 $896.42
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 644 $885.48
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 235 $881.14
82150 <1% 142 $865.21
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 212 $827.77
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 13 $816.23
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 124 $765.68
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 363 $738.42
76536 <1% 12 $735.20
82570 <1% 176 $712.66
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 179 $709.44
87205 <1% 213 $664.35
84100 <1% 235 $633.65
71250 <1% 32 $607.52
76770 <1% 12 $585.77
93016 <1% 37 $582.01
73080 <1% 42 $579.62
81002 <1% 215 $563.47
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 753 $485.39
97166 <1% 15 $473.07
82785 <1% 29 $457.23
J2060 Injection, lorazepam, 2 mg <1% 723 $426.53
73090 <1% 30 $394.09
77080 <1% 41 $392.55
J7030 Infusion, normal saline solution , 1000 cc <1% 1,181 $372.01
93018 <1% 37 $334.88
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 44 $303.60
J1815 Injection, insulin, per 5 units <1% 105 $303.20
82746 <1% 26 $300.95
J1630 Injection, haloperidol, up to 5 mg <1% 286 $271.85
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 108 $267.68
82378 <1% 18 $203.85
84156 <1% 51 $191.76
J8540 Dexamethasone, oral, 0.25 mg <1% 93 $191.37
73502 <1% 13 $189.42
G0008 Administration of influenza virus vaccine <1% 32 $160.89
82390 <1% 12 $137.23
J8597 Antiemetic drug, oral, not otherwise specified <1% 1,373 $135.58
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,252 $132.36
82247 <1% 21 $116.97
82565 <1% 24 $108.72
84550 <1% 29 $104.39
73590 <1% 12 $102.95
J3475 Injection, magnesium sulfate, per 500 mg <1% 40 $101.53
J3370 Injection, vancomycin hcl, 500 mg <1% 12 $94.68
A9585 Injection, gadobutrol, 0.1 ml <1% 100 $78.96
90686 <1% 16 $68.41
96376 <1% 19 $64.98
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 160 $63.95
93017 <1% 13 $43.05
36416 <1% 14 $39.00
77063 Screening digital breast tomosynthesis, bilateral <1% 603 $20.64
J3480 Injection, potassium chloride, per 2 meq <1% 19 $17.05
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 59 $14.93
97802 0% 50 $0.00
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 0% 21 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 28 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 0% 106 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 0% 13 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 40 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 55 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEACH, TRAVIS (PRESIDENT)
Parent organizationTRINITY HEALTH OREGON-IDAHO INC